A New Drug For A Relentless Brain Disease

A New Drug For A Relentless Brain Disease

Up next

Is your favorite crime show rooted in fake science?

If you’ve ever seen a crime show, you probably know how the plot unfolds: A victim is found, an investigation ensues and police conduct a high-stakes search for the culprit. Detectives and crime lab techs collect hair, examine bullet casings and photograph bloodstains. But just h ...  Show more

MAHA’s midterm report card

It’s been just over two years since the rise of Make America Healthy Again, or MAHA. The movement united a coalition of moms, wellness influencers and voters across the political spectrum over concerns about chronic illness and childhood diseases. And when Robert F. Kennedy Jr. t ...  Show more

Recommended Episodes

ALS Patients Take on the FDA
Distillations | Science History Institute

ALS is a fatal neurological disease that kills motor neurons. Even though it was first described more than 150 years ago, there is no cure, and the few drugs available only dampen the symptoms or slow the progression by a few months. In recent years new drugs have emerged. How ...

  Show more

Declining ALS Patients Are Waiting On The FDA's Next Move
Big Take

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ...  Show more

Audio long read: Conquering Alzheimer’s — a look at the therapies of the future
Nature Podcast

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  Show more